Concepedia

Author

Thomas Ciossek

Boehringer Ingelheim (Germany)ORCID

Also Known As

T Ciossek, Thomas Ciossek

35

Publications

2.8K

Citations

26

H-Index

84

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Max Planck Institute of BiochemistryMax Planck SocietyUniversity of RegensburgUniversity of Konstanz
TC

About

Thomas Ciossek is an author at Boehringer Ingelheim (Germany) specializing in medicine, cell biology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

18

1.4K

2

Natural Sciences

6

6

262

3

Biochemistry

6

6

369

4

Engineering

1

1

17

5

Social Sciences

1

1

25

Thomas Ciossek

×

29

Publications

2.5K

Citations

25

H-Index

YearCitations

Ephrin-A5 Induces Collapse of Growth Cones by Activating Rho and Rho Kinase

Siegfried Wahl, Holger Barth, Thomas Ciossek,

The Journal of Cell Biology

2000

391

Modulation of EphA Receptor Function by Coexpressed EphrinA Ligands on Retinal Ganglion Cell Axons

Martin R. Hornberger, Dieter Dütting, Thomas Ciossek,

Neuron

1999

357

Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group

Thomas Beckers, Carmen Burkhardt, H. Wieland,

International Journal of Cancer

2007

194

Opposing Gradients of Ephrin-As and EphA7 in the Superior Colliculus Are Essential for Topographic Mapping in the Mammalian Visual System

Tahira Rashid, A. Louise Upton, Aida Blentic,

Neuron

2005

169

Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo

Owen Scudamore, Thomas Ciossek

Journal of Neuropathology & Experimental Neurology

2018

142

Characterization of KIF1C, a New Kinesin-like Protein Involved in Vesicle Transport from the Golgi Apparatus to the Endoplasmic Reticulum

Cornelia Dorner, Thomas Ciossek, Susanne Müller,

Journal of Biological Chemistry

1998

139

Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity

Siavosh Mahboobi, Andreas Sellmer, Mathias Winkler,

Journal of Medicinal Chemistry

2010

96

Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases

Siavosh Mahboobi, Stefan Dove, Andreas Sellmer,

Journal of Medicinal Chemistry

2009

90

Lower Affinity of Isradipine for L-Type Ca <sup>2+</sup> Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease

Nadine J. Ortner, Gabriella Bock, Antonios Dougalis,

Journal of Neuroscience

2017

88

Control of triglyceride storage by a WD40/TPR‐domain protein

Thomas Häder, Sandra Müller, Miguel Aguilera,

EMBO Reports

2003

76

Page 1